If fatigue is severe, persistent, or comes with dizziness, do not wait
8 Conclusions Semaglutide, like many other GLP-1R agonists, is used in diabetes and obesity to decrease glucose levels and manage body weight, which plays a role in tumorigenesis
R., de Mutsert, R., & Numans, M
Challenges include gastrointestinal side effects, nutritional deficiencies due to calorie reduction, muscle and bone loss, low long-term adherence with subsequent weight regain, and high costs, resulting in low cost-effectiveness
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia, a sweeping new study suggests